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Conclusions: Urgent carotid endarterectomy or carotid artery stent-
ing after thrombolysis for stroke may be safe without an increased risk of
serious complications.
Summary: There is increasing evidence supporting the role of early
carotid endarterectomy (CEA) for severe carotid stenosis in the emergent
treatment of stroke. In addition, thrombolysis in hyperacute treatment of
cerebrovascular ischemia has also gradually increased. Increasing use of
thrombolysis to treat acute cerebral ischemia along with earlier surgery or
stenting for ischemic stroke makes it likely that the number of patients
who have received thrombolytic therapy and are considered for carotid
bifurcation intervention, will increase. There is, however, little known about
the results and safety of early CEA or carotid artery stenting (CAS) after
thrombolytic therapy for acute cerebral ischemia. In this study the authors
conducted a review of prospectively collected data in the Swedish National
Registry for Vascular Surgery (Swedvasc) and the Swedish Stroke Registry
(Riks-Stroke) from May 1, 2008 to December 11, 2012. The goal was to
investigate the safety of urgently performed CEA or CAS in patients treated
with thrombolysis for stroke. There were 3998 patients who underwent
CEA or CAS for symptomatic carotid stenosis between May 2008 and
December 2012. 79 of these patients (2%) had undergone previous throm-
bolysis for stroke. Retrospective review of this data and individual case re-
cords with regard to postoperative complications was performed.
Variables analyzed included surgical-site bleeding, stroke, and death. Out-
comes were compared to results of the patient cohort of 3919 patients un-
dergoing carotid surgery or stenting during the study period without pre-
procedure thrombolysis. Median time between thrombolysis and the carotid
bifurcation procedure was 10 days. There were 71 patients who underwent
carotid endarterectomy and 6 patients who underwent carotid artery stent-
ing after thrombolysis for acute stroke. 30-day death and stroke rate for the
thrombolysis cohort was 2.5% (2 or 79) and for the entire cohort it was 3.8%
(139 of 3626; P ¼ .55). Postoperative bleeding rates were not signiﬁcantly
different between the groups (3.8% in the thrombolysis group vs 3.3% in the
whole cohort; P ¼ .79). There was no correlation between time from lysis to
surgery or stenting and complications at 30 days postoperatively.
Comment: In this series, urgent procedures for high-grade carotid ar-
tery stenosis did not appear to carry an increased risk of complications after
thrombolysis for stroke. However, the median time between thrombolysis
and the carotid procedure was 10 days and it is possible that earlier surgery
could have an increased rate of complications. The timing of surgery
following thrombolytic therapy for acute stroke must be balanced against
the risk of further cerebral ischemic events. This study is by no means deﬁn-
itive as it is small and retrospective in design. It is based on a registry data
collection with all those inherent limitations. However, there is nothing
here to indicate that an urgent carotid procedure at least at a median of
10 days following thrombolysis for acute stroke is of increased risk
compared to CEA or CAS for symptomatic carotid stenosis without preced-
ing thrombolysis.
Open Aortic Repair After Prior Thoracic Endovascular Aortic Repair
Roselli EE, Abdel-Halim M, Johnston DR, et al. Ann Thorac Surg
2014;97:750-7.
Conclusions: There are a variety of indications for conversion to open
repair after thoracic endovascular stent grafting. The operations are compli-
cated and the long term results are consistent with the chronic disease state
of the patients.
Summary: Since the induction of thoracic endovascular stent grafting
the technique has inevitably been applied to increasingly complex aortic pa-
thology. In fact, it is now estimated that nearly two-thirds of thoracic aortic
stent grafts are deployed outside the instructions for use, or “off-label”.
Inevitably it is to be expected that the use of this technique for increasingly
complex aortic pathology is going to result in some late complications.
Some of these late complications will require conversion to open repair.
The objectives of this study were to: (1) characterize patients undergoing
open thoracic areas repair after prior TEVAR, (2) assess the indications
for conversion and operative techniques used, and (3) assess late and early
outcomes. The authors performed a chart review of their prospectively264collected database of patients undergoing thoracic endovascular arterial
repair. They identiﬁed 50 patients who underwent a follow-up open aortic
operation after prior TEVAR. The patients were also analyzed with the So-
cial Security information for vital status. From July 2001 to January 2012
open arch (n ¼ 25), descending (n ¼ 6), thoracoabdominal (n ¼ 17),
or extra-anatomic bypass (n ¼ 2) operations were performed after previous
TEVAR. Median time from TEVAR to the open surgical procedure was
13.9 months with an interquartile range of 0.5 to 24 months. Indications
for open operation included type endoleaks (n ¼ 19), retrograde aortic
dissection (n ¼ 9), chronic aortic dissection with persistent false lumen
growth (n ¼ 16), and graft infection (n ¼ 6). 60% of the patients had prior
cardiovascular surgical procedures and 18% were done as emergencies.
Circulatory support was required in 78% of the patients and hypothermic
arrest techniques were used in 48%. Hospital mortality was 6% with no
strokes and 1 myocardial infarction. 10% of patients (n ¼ 5) required trache-
ostomy and 1 required dialysis. Survival was 67% at a median follow-up
of 2.9 years.
Comment: New procedures bring with them new complications.
New complications will require innovative approaches. In this series the
types of operations could be broadly classiﬁed as conversions to conven-
tional repair and so-called reverse frozen elephant trunk, hybrid debranch-
ing procedures and extra-atomic bypass with subsequent stent graft
removal and aortic oversew. Despite the author’s excellent results with these
highly complicated operations in difﬁcult patients, with only 6% periopera-
tive mortality, and no strokes or paraplegia, results are not likely generaliz-
able to centers with less experience in the management of difﬁcult thoracic
aortic patients. Interestingly enough, like with open operations in the pres-
ence of abdominal aortic endografts, the stent graft itself can many times be
preserved, at least partially, in these procedures. When sewing to the stent
graft itself the authors advise including the adventitial layer of the aorta in
the anastomosis, such that the previous stent graft is somewhat analogous
to a new intimal layer.
Ultrasonography Screening for Abdominal Aortic Aneurysms: A
Systematic Evidence Review for the U.S. Preventive Services Task
Force
Guirguis-Blake JM, Beil TL, Senger CA, et al. Ann Intern Med
2014;160:321-9.
Conclusions: A one-time invitation for abdominal aortic aneurysm
(AAA) screening in men aged 65 years or older is associated with decreased
AAA rupture and AAA-related mortality rates but has little or no effect on
all-cause mortality.
Summary: Long-term follow-up and population-based randomized,
controlled trials, have demonstrated that screening for AAAs $3 cm in
diameter, decreases AAA related mortality rates in men aged 65 years or
older. The U.S. Preventative Services Task Force (USPSTF) evaluates
screening modalities for various diseases with respect to both beneﬁts and
harms. In 2005, the USPSTF found evidence to recommend 1-time
screening for AAA by ultrasonography in men aged 65 to 75 years who
had ever smoked. At that time, the USPSTF concluded beneﬁts sustained
did not clearly outweigh the harms and did not make a general recommen-
dation for or against screening for AAA in men aged 65 to 75 years who had
never smoked. They also recommended against routine screening for AAA
in women (U.S. Preventative Services Task Force, Ann Intern Med 2005;
42:198-202). In the current paper the USPSTF have included newly iden-
tiﬁed literature and all trials from the previous review that met current inclu-
sion criteria in an effort to provide updated evidence on the effectiveness of
1-time and repeated ultrasound screening for AAAs. Data sources included
MEDLINE, the Database of Abstracts of Reviews of Effects, the Cochrane
Central Register of Controlled Trials (Jan 2004-Jan 2013), clinical trial reg-
istries, references, experts, and a targeted search for population-based
screening randomized clinical trials through September 2013. Studies
were selected if they were in the English language, were population-based,
of fair to good quality and randomized. Large cohort studies for AAA
screening beneﬁts as well as randomized clinical trials and cohort or registry
studies for harms in adults with AAA were also included. Overall review of
four RCTs involving 137,214 participants demonstrated that a 1-time invi-
tation for AAA screening in men aged 65 years or older reduced AAA
rupture and AAA-related mortality rates for 10 to 15 years, respectively.
There was, however, no statistically signiﬁcant effect of all-cause mortality
